NYSE: BMY

Price$54.78 Change +0.19 %Change +0.35% Volume: 26,861,211 20 minute delay February 21, 2017

SEC Filings

Date Filing Description Download
Nov 14, 1997 10-Q Quarterly Report
Aug 11, 1997 424B5 Prospectus filed pursuant to Rule 424(b)(5)
Aug 07, 1997 10-Q Quarterly Report
Jun 30, 1997 SE Form for submission of Paper Format Exhibits by Electronic Filers
May 15, 1997 10-Q Quarterly Report
Mar 31, 1997 10-K Annual Report
Mar 27, 1997 AR/S Paper Annual Report to Security Holders
Mar 21, 1997 DEF 14A Proxy Statement (definitive)
Mar 04, 1997 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary)
Feb 13, 1997 SC 13G Statement of Ownership
Feb 03, 1997 SC 13G Statement of Ownership
Feb 03, 1997 SC 13G Statement of Ownership
Jan 28, 1997 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders
Jan 23, 1997 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders
Jan 22, 1997 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.